Aytu BioPharma Ownership 2024 | Who Owns Aytu BioPharma Now?
Institutional Ownership
0.15%
Insider Ownership
3.33%
Retail Ownership
96.52%
Institutional Holders
1.00
Aytu BioPharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RONALD BLUE TRUST, INC. | - | - | - | -5,579 | -100.00% | - | Jun 30, 2023 |
Aytu BioPharma's largest institutional shareholder is RONALD BLUE TRUST, INC., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RONALD BLUE TRUST, INC. | - | - | - | -5,579 | -100.00% | - | Jun 30, 2023 |
The largest Aytu BioPharma shareholder by % of total assets is RONALD BLUE TRUST, INC.. The company owns 0.00 shares of Aytu BioPharma (AYTU), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RONALD BLUE TRUST, INC. | - | - | - | -5,579 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Aytu BioPharma's largest institutional buyer is RONALD BLUE TRUST, INC.. The company purchased -5.58K stocks of AYTU, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RONALD BLUE TRUST, INC. | - | - | - | -5,579 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Aytu BioPharma's biggest institutional seller is RONALD BLUE TRUST, INC.. The company sold -5.58K shares of AYTU, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RONALD BLUE TRUST, INC. | - | - | - | -5,579 | -100.00% | - | Jun 30, 2023 |
Aytu BioPharma's largest sold out institutional shareholder by shares sold is RONALD BLUE TRUST, INC., sold -5.58K shares, valued at -, as of undefined.
Aytu BioPharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD INDEX FUNDS | 0.01% | 5,362,815 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,291 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 16,320 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 39,773 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,570 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.01% | 183,417 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 31,207 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 42,552 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 714,642 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 110,060 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 6,623 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 972,699 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 241,272 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,021 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,780 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 1,500 | 1,500 | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,927 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 189 | - | - | Apr 30, 2021 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 1,279 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 662 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 237,935 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,569 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 8,368 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 34,384 | 26,598 | 341.61% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 177,308 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 12,896 | - | - | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 5,262 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 11,054 | - | - | Mar 28, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 29,651 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 17,065 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 27,888 | -26,614 | -48.83% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 804 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,050 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 243,847 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,500 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 194,923 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 475 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,334 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 10,939 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 2,484 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 10,388 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 63,353 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,057 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,806 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,409 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 24,129 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 5,258 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 68,371 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 41,322 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,276 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 37,551 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 206 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 924 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,555 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,367 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 2,248 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,035 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 12,088 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,351 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 3,228 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 65 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,737 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 2,637 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 890 | -7,147 | -88.93% | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 8,435 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 6,469 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 8,042 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 25,328 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,026 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,484 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,216 | - | - | Feb 29, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,973 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 1,633 | - | - | Mar 28, 2024 |
Aytu BioPharma's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 5.36M shares, compromising 0.01% of its total assets.
Aytu BioPharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 1 | -96.88% |
| 31 Dec, 22 | 32 | -8.57% |
| 30 Sep, 22 | 35 | 29.63% |
| 30 Jun, 22 | 27 | - |
| 31 Mar, 22 | 27 | -27.03% |
| 31 Dec, 21 | 37 | - |
| 30 Sep, 21 | 37 | -27.45% |
| 30 Jun, 21 | 51 | -13.56% |
| 31 Mar, 21 | 59 | 55.26% |
| 31 Dec, 20 | 38 | - |
As of 31 Mar 23, 1 institutions are holding Aytu BioPharma's shares, representing a decrease of -96.88% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 5,579 | -99.93% |
| 31 Dec, 22 | 7,742,624 | -8.93% |
| 30 Sep, 22 | 8,501,749 | 142.28% |
| 30 Jun, 22 | 3,509,030 | -35.21% |
| 31 Mar, 22 | 5,415,935 | 48.63% |
| 31 Dec, 21 | 3,643,962 | -10.21% |
| 30 Sep, 21 | 4,058,241 | -25.31% |
| 30 Jun, 21 | 5,433,130 | -13.47% |
| 31 Mar, 21 | 6,278,883 | 46.62% |
| 31 Dec, 20 | 4,282,317 | - |
Aytu BioPharma (AYTU) has 5.58K shares outstanding as of 31 Mar 23, down -99.93% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 0.15% | 0.10% |
| 31 Dec, 22 | 12.45% | 6.66% |
| 30 Sep, 22 | 13.67% | 14.36% |
| 30 Jun, 22 | 9.75% | 2.93% |
| 31 Mar, 22 | 18.24% | 9.58% |
| 31 Dec, 21 | 13.80% | 5.49% |
| 30 Sep, 21 | 15.85% | 1.51% |
| 30 Jun, 21 | 32.44% | 2.69% |
| 31 Mar, 21 | 34.70% | 3.34% |
| 31 Dec, 20 | 32.24% | - |
As of 31 Mar 23, Aytu BioPharma is held by 0.15% institutional shareholders, representing a 0.10% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | - | -100.00% |
| 31 Dec, 22 | 15 | -11.76% |
| 30 Sep, 22 | 17 | 13.33% |
| 30 Jun, 22 | 15 | 66.67% |
| 31 Mar, 22 | 9 | -35.71% |
| 31 Dec, 21 | 14 | -12.50% |
| 30 Sep, 21 | 16 | -33.33% |
| 30 Jun, 21 | 24 | -46.67% |
| 31 Mar, 21 | 45 | 18.42% |
| 31 Dec, 20 | 38 | - |
- institutional shareholders have increased their position in AYTU stock as of 31 Mar 23 compared to 15 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | - | -100.00% |
| 31 Dec, 22 | 9 | -10.00% |
| 30 Sep, 22 | 10 | 42.86% |
| 30 Jun, 22 | 7 | -41.67% |
| 31 Mar, 22 | 12 | -14.29% |
| 31 Dec, 21 | 14 | 27.27% |
| 30 Sep, 21 | 11 | -26.67% |
| 30 Jun, 21 | 15 | 150.00% |
| 31 Mar, 21 | 6 | - |
| 31 Dec, 20 | - | - |
- institutional shareholders have reduced their position in AYTU stock as of 31 Mar 23 compared to 9 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 1 | -96.88% | 5,579 | -99.93% | 0.15% | 0.10% | - | -100.00% | - | -100.00% |
| 31 Dec, 22 | 32 | -8.57% | 7,742,624 | -8.93% | 12.45% | 6.66% | 15 | -11.76% | 9 | -10.00% |
| 30 Sep, 22 | 35 | 29.63% | 8,501,749 | 142.28% | 13.67% | 14.36% | 17 | 13.33% | 10 | 42.86% |
| 30 Jun, 22 | 27 | - | 3,509,030 | -35.21% | 9.75% | 2.93% | 15 | 66.67% | 7 | -41.67% |
| 31 Mar, 22 | 27 | -27.03% | 5,415,935 | 48.63% | 18.24% | 9.58% | 9 | -35.71% | 12 | -14.29% |
| 31 Dec, 21 | 37 | - | 3,643,962 | -10.21% | 13.80% | 5.49% | 14 | -12.50% | 14 | 27.27% |
| 30 Sep, 21 | 37 | -27.45% | 4,058,241 | -25.31% | 15.85% | 1.51% | 16 | -33.33% | 11 | -26.67% |
| 30 Jun, 21 | 51 | -13.56% | 5,433,130 | -13.47% | 32.44% | 2.69% | 24 | -46.67% | 15 | 150.00% |
| 31 Mar, 21 | 59 | 55.26% | 6,278,883 | 46.62% | 34.70% | 3.34% | 45 | 18.42% | 6 | - |
| 31 Dec, 20 | 38 | - | 4,282,317 | - | 32.24% | - | 38 | - | - | - |
Aytu BioPharma Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Aytu BioPharma's stock was made by PYSZCZYMUKA GREG on Jul 02 2024, selling 208 shares at - per share (valued at -).
Aytu BioPharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | 2 | 100.00% |
| Q1 2024 | 1 | 1 | 100.00% |
| Q4 2023 | 1 | 1 | 100.00% |
| Q3 2023 | 11 | 1 | 1100.00% |
| Q2 2023 | 4 | 2 | 200.00% |
| Q1 2023 | 1 | - | - |
| Q4 2022 | 6 | 10 | 60.00% |
| Q3 2022 | 1 | - | - |
| Q1 2022 | 1 | - | - |
| Q2 2021 | 7 | - | - |
| Q1 2021 | 3 | 3 | 100.00% |
| Q4 2020 | 2 | - | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | 14 | 5 | 280.00% |
| Q1 2020 | 12 | 10 | 120.00% |
| Q4 2019 | 10 | 1 | 1000.00% |
| Q2 2019 | 4 | - | - |
| Q1 2019 | 3 | 3 | 100.00% |
| Q4 2018 | 8 | 1 | 800.00% |
| Q1 2018 | 7 | - | - |
2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Aytu BioPharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 2 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 4 | - | - |
| Q3 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 2 | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | 3 | - |
| Q1 2020 | - | 4 | - |
| Q4 2019 | 8 | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | 1 | 1 | 100.00% |
| Q1 2018 | 6 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Aytu BioPharma's stocks.
Aytu BioPharma Peer Ownership
| Ticker | Company |
|---|---|
| SNOA | Sonoma Pharmaceuticals, Inc. |
| FLGC | Flora Growth Corp. |
| EVOK | Evoke Pharma, Inc. |
| AQST | Aquestive Therapeutics, Inc. |
| SBFM | Sunshine Biopharma, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| ESPR | Esperion Therapeutics, Inc. |
| GHSI | Guardion Health Sciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| ALIM | Alimera Sciences, Inc. |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
| DERM | Journey Medical Corporation |
| ACRX | Talphera, Inc. |
| PTPI | Petros Pharmaceuticals, Inc. |
| JUPW | Safety Shot Inc |
| ADMP | Adamis Pharmaceuticals Corporation |
| SXTC | China SXT Pharmaceuticals, Inc. |
| NEPT | Neptune Wellness Solutions Inc. |
| AVDL | Avadel Pharmaceuticals plc |
AYTU Ownership FAQ
Who Owns Aytu BioPharma?
Aytu BioPharma is owned by institutional shareholders (0.15%), insiders (3.33%), and public (96.52%). The largest institutional shareholder of Aytu BioPharma is RONALD BLUE TRUST, INC. (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.01% of total shares).
Who are the major institutional shareholders of Aytu BioPharma?
Aytu BioPharma's major institutional shareholders are RONALD BLUE TRUST, INC.. The top five shareholders own together 0% of the company's share outstanding.
How many Aytu BioPharma shareholders are there?
As of Mar 2023, there are 1 institutional shareholders of Aytu BioPharma.
What percentage of Aytu BioPharma is owned by RONALD BLUE TRUST, INC?
RONALD BLUE TRUST, INC owns 0 shares of Aytu BioPharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).